With a market cap of $60.4 billion, Axon Enterprise, Inc. (AXON) develops and sells performed vitality gadgets underneath the TASER model, together with physique cameras, software program, and digital proof administration options for public security. The corporate serves legislation enforcement, federal, corrections, healthcare, retail, and private security markets worldwide.
Shares of the Scottsdale, Arizona-based firm have considerably outperformed the broader market over the previous 52 weeks. AXON inventory has jumped 112.7% over this timeframe, whereas the broader S&P 500 Index ($SPX) has returned 15.2%. Furthermore, shares of the corporate are up 29.7% on a YTD foundation, in comparison with SPX’s 10.2% rise.
Focusing extra carefully, the TASER maker inventory has additionally outpaced the Industrial Choose Sector SPDR Fund’s (XLI) 19.1% enhance over the previous 52 weeks and a 16.8% YTD acquire.
Shares of Axon jumped 16.4% following its Q2 2025 outcomes on Aug. 4 as adjusted EPS got here in at $2.12, exceeding Wall Road estimates. Income rose to $668.5 million, beating expectations and reflecting sturdy demand for TASER gadgets, physique cameras, and software program options. The corporate additionally raised its full-year 2025 income forecast to $2.65 billion – $2.73 billion, signaling confidence in continued development from federal spending and govt safety demand.
For the fiscal 12 months ending in December 2025, analysts anticipate Axon Enterprise’s EPS to say no 54.6% year-over-year to $0.95. The corporate’s earnings shock historical past is combined. It topped the consensus estimates in two of the final 4 quarters whereas lacking on two different events.
Among the many 18 analysts overlaying the inventory, the consensus ranking is a “Sturdy Purchase.” That’s based mostly on 13 “Sturdy Purchase” rankings, three “Reasonable Buys,” and two “Holds.”
This configuration is extra bullish than three months in the past, with 10 “Sturdy Purchase” rankings on the inventory.
On Aug. 5, Northland analyst Michael Latimore raised Axon’s worth goal to $800 with an “Outperform” ranking.
The imply worth goal of $869.73 represents a virtually 13% premium to AXON’s present worth ranges. The Road-high worth goal of $940 suggests a 22.1% potential upside.
On the date of publication, Sohini Mondal didn’t have (both instantly or not directly) positions in any of the securities talked about on this article. All data and information on this article is solely for informational functions. This text was initially printed on Barchart.com
